Oncology
4 drugs are in development for Fallopian Tube Cancer.
- Companies
- 4
- Clinical trials
- 43
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Fallopian Tube Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| STRO-002 | SUTRO BIOPHARMA, INC. (STRO) |
Phase 1(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| olvi-vec | GENELUX Corp (GNLX) |
About this indication
Fallopian Tube Cancer context
Oncology·MeSH: Fallopian Tube Neoplasms (D005185)
Compare drugs
Frequently asked questions
How many drugs are in development for Fallopian Tube Cancer?
BioSniper tracks 4 drugs in development for Fallopian Tube Cancer across 4 companies.
How many clinical trials target Fallopian Tube Cancer?
There are 43 clinical trials targeting Fallopian Tube Cancer tracked by BioSniper.